Inflammatory Rasch-built Overall Disability Scale (I-RODS) for patients with Guillain–Barré syndrome, chronic inflammatory demyelinating polyneuropathy and polyneuropathy with monoclonal gammopathy of undetermined significance: linguacultural ratification in Russia for patients with chronic inflammatory demyelinating polyneuropathy
Authors:
- N. A. SuponevaNSN. A. Suponeva
- Alina S. ArestovaAAAlina S. Arestova
- Е. А. MelnikЕMЕ. А. Melnik
- A. A. ZiminAZA. A. Zimin
- A. M. NarbutANA. M. Narbut
- А. YakubuАYА. Yakubu
- E. S. ShcherbakovaESE. S. Shcherbakova
- A. B. ZaytsevAZA. B. Zaytsev
- D. A. GrishinaDGD. A. Grishina
- D. G. YusupovaDYD. G. Yusupova
- E. V. GnedovskayaEGE. V. Gnedovskaya
- M. A. PiradovMPM. A. Piradov
Open Access
- 6 March 2026
- journal article
- Published by Publishing House ABV Press in Neuromuscular Diseases
- Vol. 15 (4) , 17-23
Abstract
Background. Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common type of dysimmune neuropathy, and it can lead to either permanent or temporary disability in about half of patients. Objective assessment of functional impairment is essential for monitoring therapeutic outcomes and disease progression in CIDP. The Inflammatory Rasch-built Overall Disability Scale (I-RODS) is one of the most valuable tools for assessing disability in CIDP patients and can be used in both clinical research and routine practice. In this article, we present the results of the validation process for this scale in Russian individuals with CIDP. Aim. To translate and validate the I-RODS for use in Russian patients with CIDP. Materials and methods. The study enrolled 50 cases of CIDP, evenly distributed between the typical variant and Lewis–Sumner syndrome. We performed linguocultural adaptation of the original version of the I-RODS using a standard protocol, after which we assessed the psychometric properties of the Russian version (i.e., its sensitivity, reliability and validity). Results. Psychometric evaluation demonstrated good reliability, sensitivity, and validity of the Russian I-RODS adaptation. Conclusion. We validated the Russian-language adaptation of the I-RODS, which can be applied in for both clinical practice and research.Keywords
This publication has 13 references indexed in Scilit:
- Patient‐Reported Outcome Measures for Assessing Health‐Related Quality of Life in Patients With Polyneuropathies, Focusing on Guillain‐Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy: A Systematic Review of Measurement PropertiesJournal of the Peripheral Nervous System, 2025
- European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revisionJournal of the Peripheral Nervous System, 2021
- Validation of the Serbian version of inflammatory Rasch‐built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathyJournal of the Peripheral Nervous System, 2019
- Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathyJournal of Neurology, Neurosurgery & Psychiatry, 2019
- CIDP diagnostic pitfalls and perception of treatment benefitNeurology, 2015
- 196th ENMC international workshop: Outcome measures in inflammatory peripheral neuropathies 8–10 February 2013, Naarden, The NetherlandsNeuromuscular Disorders, 2013
- Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathiesNeurology, 2011
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First RevisionEuropean Journal of Neurology, 2010
- 131st ENMC International workshop: Selection of Outcome Measures for Peripheral Neuropathy Clinical TrialsNeuromuscular Disorders, 2006
- Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathyAnnals of Neurology, 2001